Profile data is unavailable for this security.
About the company
Immuno-Biological Laboratories Co., Ltd. is a Japan-based company engaged in the research, development, manufacture and sales of pharmaceutical products and quasi-drugs. The Company operates in four business segments. The Diagnostic and Reagent segment is engaged in the manufacture, purchase and sales of research-related reagents, medicine, as well as vitro diagnostics. The Genetically Modified Silkworm segment is engaged in the sales of transgenic silkworm cocoons related products and research development of pharmaceutical raw materials. The Testing segment is engaged in the provision of support for prevention and diagnosis in addition to drug discovery and research support in the field of lifestyle-related diseases using lipid metabolism analysis technology. The Cosmetics segment is engaged in the sales of cosmetics and other products.
- Revenue in JPY (TTM)869.12m
- Net income in JPY226.88m
- Incorporated1982
- Employees57.00
- LocationImmuno-Biological Laboratories Co Ltd1091-1, Naka Aza-HigashidaFUJIOKA-SHI 375-0005JapanJPN
- Phone+81 274222889
- Fax+81 274236055
- Websitehttps://www.ibl-japan.co.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Muromachi Chemicals Inc | 6.37bn | 330.20m | 3.13bn | 205.00 | 9.35 | 1.34 | 6.72 | 0.4919 | 81.78 | 81.78 | 1,578.94 | 571.26 | 1.27 | 4.82 | 4.16 | 31,068,770.00 | 6.60 | 5.23 | 10.39 | 10.08 | 29.12 | 30.02 | 5.18 | 4.39 | 1.62 | 40.73 | 0.3876 | 22.95 | 1.24 | 3.28 | 28.83 | 62.76 | -7.95 | -- |
Liberta Co Ltd | 7.89bn | -20.40m | 3.48bn | 118.00 | -- | 2.26 | 24.65 | 0.4409 | -3.49 | -3.49 | 1,325.93 | 256.06 | 1.21 | 2.88 | 5.72 | 66,877,950.00 | -0.3155 | 3.75 | -0.6765 | 6.42 | 37.15 | 41.81 | -0.2615 | 2.37 | 0.8419 | -- | 0.7196 | 35.67 | 6.77 | 9.76 | -2.77 | -12.85 | 23.12 | -- |
Kubota Pharmaceutical Holdings Co Ltd | 32.44m | -1.41bn | 3.55bn | 12.00 | -- | 1.75 | -- | 109.59 | -25.21 | -25.21 | 0.5784 | 36.04 | 0.0106 | 0.2228 | -- | 2,703,333.00 | -46.21 | -36.51 | -50.76 | -39.47 | 76.16 | -- | -4,358.35 | -13,528.87 | 8.51 | -- | 0.0604 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
Immuno-Biological Laboratories Co., Ltd. | 869.12m | 226.88m | 3.96bn | 57.00 | 17.45 | 3.01 | 73.82 | 4.55 | 24.36 | 24.36 | 93.32 | 141.37 | 0.5582 | 0.9352 | 4.06 | 15,247,630.00 | 14.57 | -13.97 | 17.43 | -16.39 | 65.48 | 57.73 | 26.11 | -39.23 | 3.58 | -- | 0.1542 | -- | 2.78 | 0.8924 | 164.44 | -- | -- | -- |
Renascience Inc | 140.67m | -277.45m | 4.02bn | 4.00 | -- | 2.53 | -- | 28.56 | -21.83 | -21.83 | 11.07 | 125.06 | 0.0659 | -- | 18.27 | 35,166,500.00 | -13.00 | -- | -13.28 | -- | 78.84 | -- | -197.24 | -- | -- | -- | 0.187 | -- | 93.11 | -- | 23.07 | -- | -- | -- |
Delta-Fly Pharma Inc | 0.00 | -1.65bn | 4.30bn | 13.00 | -- | 5.88 | -- | -- | -214.95 | -214.95 | 0.00 | 89.00 | 0.00 | -- | -- | 0.00 | -204.19 | -67.70 | -226.67 | -72.02 | -- | -- | -- | -877.69 | -- | -406.70 | 0.00 | -- | -- | -- | -7.57 | -- | -9.04 | -- |
MEDRx Co Ltd | 254.05m | -511.95m | 4.36bn | 22.00 | -- | 1.63 | -- | 17.15 | -13.76 | -13.76 | 6.54 | 56.60 | 0.119 | 0.00 | 19.15 | 11,547,680.00 | -23.98 | -58.15 | -24.39 | -62.23 | 8.88 | 95.70 | -201.52 | -1,526.17 | 52.29 | -- | 0.00 | -- | -50.35 | 28.60 | 16.04 | -- | -55.29 | -- |
NIPPON CHEMIPHAR CO., LTD. | 31.21bn | -133.00m | 6.82bn | 887.00 | -- | 0.3142 | 5.28 | 0.2186 | -36.85 | -36.85 | 8,647.86 | 5,095.28 | 0.6053 | 2.06 | 2.79 | 35,182,640.00 | -0.258 | 0.7482 | -0.3663 | 1.08 | 25.57 | 30.99 | -0.4262 | 1.13 | 1.53 | -- | 0.4954 | 50.73 | -2.57 | -2.10 | -153.10 | -- | 24.62 | -12.94 |
COSMO BIO COMPANY, LIMITED | 9.64bn | 339.00m | 6.96bn | 155.00 | 19.82 | 0.7333 | 14.18 | 0.722 | 58.08 | 58.08 | 1,651.14 | 1,569.72 | 0.8536 | 6.07 | 3.81 | 62,206,450.00 | 3.11 | 5.62 | 3.62 | 6.72 | 33.17 | 37.40 | 3.64 | 6.23 | 6.28 | -- | 0.002 | 33.53 | -2.23 | 5.16 | -14.51 | 11.20 | -8.03 | 16.47 |